The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Of the 167 patients enrolled, 85.6% completed the study (figure 1). A greater proportion of placebo-treated patients discontinued early (21% vs 11% in the alendronic acid group), but no meaningful ...

Earlier studies demonstrated that alendronate is not effective for relieving bone density, reducing bone turnover blank and reducing the risk of men. Bisphosphonates are currently the pre-eminent ...

A woman from Pembrokeshire says she "has been left with this fear" after a medicine she was taking has weakened her bones. Shirley David from Milton had been taking Alendronic acid for 11 years. The ...

Men aged 25 90 years with hypogonadal or idiopathic osteoporosis were studied at 13 centres in the US. Inclusion in the trial was based on: (a) BMD at least 2 standard deviations (SD) below the mean ...